United States Intervenes and Files Complaint in False Claims Act Suit Against Health Insurer for Submitting Unsupported Diagnoses to the Medicare Advantage Program

DOJ

The United States has intervened and filed a complaint in the U.S. District Court for the Western District of New York under the False Claims Act against Independent Health Association, Independent Health Corporation (Independent Health), DxID LLC (DxID) and Betsy Gaffney, former CEO of DxID. The government alleges that Independent Health, DxID and Gaffney violated the False Claims Act by submitting or causing the submission of inaccurate information about the health status of beneficiaries enrolled in Medicare Advantage Plans in order to increase Independent Health’s reimbursement. Independent Health is headquartered in Buffalo, New York. DxID was headquartered in Buffalo until it ceased operations in August. read more »

U.S. SEC chief takes broad aim at financial industry in Senate hearing

REUTERS

U.S. Securities and Exchange Commission (SEC) Chair Gary Gensler took aim at the gamut of financial sectors, from the treasury and equity markets to digital assets, as he mapped out his ambitious agenda before the Senate Banking Committee on Tuesday. read more »

Former Theranos employees to take the stand in Elizabeth Holmes trial

WASHINGTON POST

The trial of Elizabeth Holmes, who is charged with wire fraud, resumed here Tuesday with expected witness testimony for the prosecution, including former employees of blood-testing company Theranos. read more »